Patents Assigned to AttenueX Technologies, Inc.
-
Patent number: 10327880Abstract: An inflated implant, such as an attenuation device, previously implanted in a urinary bladder can later be removed according to a number of different methods. Preferably, removal is accomplished transurethrally. In one embodiment, removal is accomplished by reducing the inflated implant from an enlarged profile to a reduced profile so that it may be withdrawn transurethrally by a removal system. The removal system can be configured differently depending upon whether reduction from the enlarged profile to the reduced profile is accomplished by deflation, compression, and/or other ways.Type: GrantFiled: August 29, 2016Date of Patent: June 25, 2019Assignee: AttenueX Technologies, Inc.Inventors: Kevin G. Connors, William L. Pintauro, Sheila K. Wallin, John T. Kilcoyne, Hung H. Cao, Khoi M. Nguyen, Matthew T. Yurek
-
Patent number: 9801658Abstract: Method and system for treating a patient using an inflatable device. A removal device may be used to remove the inflatable device from the body. The removal device can have at least one manually-actuatable member and at least two opposing jaws at a distal end. At least one of the at least two jaws can be movable by actuation of the at least one manually-actuatable member. At least one of the at least two jaws can have a puncturing member.Type: GrantFiled: March 27, 2015Date of Patent: October 31, 2017Assignee: AttenueX Technologies, Inc.Inventors: Kevin G. Connors, Ryan J. Cahill
-
Patent number: 9615911Abstract: An implant delivery system can be used to deliver an implant into a body. The implant delivery system can include an inflation tube and a tubular member surrounding the inflation tube. The inflation tube can be used to provide an inflation medium to the implant. The tubular member can have a distal tip and an opening spaced from the tip to allow the implant to be released through the opening into an anatomical structure within the body.Type: GrantFiled: February 20, 2015Date of Patent: April 11, 2017Assignee: AttenueX Technologies, Inc.Inventors: Kevin G. Connors, Hung Cao
-
Patent number: 9498195Abstract: An implant for use in a human or animal body can include a flexible housing with an outer wall and having a chamber therein. The implant can have at least one high vapor pressure medium within the chamber. The at least one high vapor pressure medium can have a combined vapor pressure equal to or greater than about the average value of the hydrostatic pressure of the implantation site plus the skin tension of the housing minus the gas tension of the dissolved gasses present at the implantation site.Type: GrantFiled: November 25, 2013Date of Patent: November 22, 2016Assignee: AttenueX Technologies, Inc.Inventors: Ernest G. Schutt, Kevin G. Connors, John Gillespie, Jr., Peter Dayton
-
Patent number: 9044209Abstract: An inflated implant within an anatomical structure, such as the bladder, may require removal. A method of removing an inflated implant from an anatomical structure can include any of a number of different steps. A removal device can be placed within the anatomical structure. The implant is located within the anatomical structure. After it is located, the implant can be engaged by arms of the removal device. A portion of a surface of the implant can be compromised such that an inflation substance within the implant can escape. The inflation substance can be removed out of the implant through a deflation tube in at least one of the arms used to engage the implant. The implant can then be removed from the anatomical structure.Type: GrantFiled: November 4, 2013Date of Patent: June 2, 2015Assignee: AttenueX Technologies, Inc.Inventors: Peter Dayton, John Gillespie, Jr., Kevin G. Connors
-
Patent number: 8992412Abstract: Method and system for treating a patient using an inflatable device. A removal device may be used to remove the inflatable device from the body. The removal device can have at least one manually-actuatable member and at least two opposing jaws at a distal end. At least one of the at least two jaws can be movable by actuation of the at least one manually-actuatable member. At least one of the at least two jaws can have a puncturing member.Type: GrantFiled: April 25, 2014Date of Patent: March 31, 2015Assignee: AttenueX Technologies, Inc.Inventors: Ryan J. Cahill, John Gillespie, Jr., Peter Dayton, Kevin G. Connors
-
Patent number: 8961392Abstract: An implant delivery system can be used to deliver an implant into a body. The implant delivery system can include an inflation tube and a tubular member surrounding the inflation tube. The inflation tube can be used to provide an inflation medium to the implant. The tubular member can have a distal tip and an opening spaced from the tip to allow the implant to be released through the opening into an anatomical structure within the body.Type: GrantFiled: September 8, 2011Date of Patent: February 24, 2015Assignee: AttenueX Technologies, Inc.Inventors: Hung Cao, Kevin G. Connors
-
Patent number: 8894563Abstract: Method and system for treating a patient using a compressible, pressure-attenuating device. According to one embodiment, the system is used to treat urinary tract disorders and comprises an access device, a delivery device, a pressure-attenuating device, and a removal device. The access device may be used to create a passageway to an anatomical structure, such as the patient's bladder. The delivery device may be inserted through the passageway created by the access device and may be used to deliver the pressure-attenuating device to the anatomical structure. The removal device may be inserted through the passageway created by the access device and may be used to view the bladder and/or to capture, to deflate and to remove the pressure-attenuating device.Type: GrantFiled: March 15, 2013Date of Patent: November 25, 2014Assignee: AttenueX Technologies, Inc.Inventors: Kevin G. Connors, Ryan J. Cahill, Peter Dayton, John Gillespie, Jr.
-
Patent number: 8882653Abstract: Method and system for treating a patient using a compressible, pressure-attenuating device. According to one embodiment, the system is used to treat urinary tract disorders and can include one or more of an access device, a delivery device, a pressure-attenuating device, and a removal device. The access device may be used to create a passageway to an anatomical structure, such as the patient's bladder. The delivery device may be inserted through the passageway created by the access device and may be used to deliver the pressure-attenuating device to the anatomical structure. The removal device may be inserted through the passageway created by the access device and may be used to view the bladder and/or to capture, to deflate and to remove the pressure-attenuating device.Type: GrantFiled: October 24, 2013Date of Patent: November 11, 2014Assignee: AttenueX Technologies, Inc.Inventors: John Gillespie, Jr., Ryan J. Cahill, Kevin G. Connors, Peter Dayton, Carla Wiese
-
Patent number: 8864649Abstract: Method and system for treating a patient using a compressible, pressure-attenuating device. According to one embodiment, the system is used to treat urinary tract disorders and can include one or more of an access device, a delivery device, a pressure-attenuating device, and a removal device. The access device may be used to create a passageway to an anatomical structure, such as the patient's bladder. The delivery device may be inserted through the passageway created by the access device and may be used to deliver the pressure-attenuating device to the anatomical structure. The removal device may be inserted through the passageway created by the access device and may be used to view the bladder and/or to capture, to deflate and to remove the pressure-attenuating device.Type: GrantFiled: September 5, 2013Date of Patent: October 21, 2014Assignee: AttenueX Technologies, Inc.Inventors: Ryan J. Cahill, Kevin G. Connors
-
Patent number: 8858460Abstract: Measurement of a patient's leak point pressure in the bladder can be taken by a processor in communication with a pressure catheter in the bladder. When leakage occurs pressure data points can be recorded. In some embodiments, the peak pressure can be determined based on pressure data points measured during a set time just before receiving a clinician input indicative that leakage has occurred.Type: GrantFiled: October 25, 2012Date of Patent: October 14, 2014Assignee: AttenueX Technologies, Inc.Inventors: Kevin G. Connors, William L. Pintauro, Sheila K. Wallin, John T. Kilcoyne, Hung H. Cao, Khoi M. Nguyen, Matthew T. Yurek
-
Publication number: 20140236208Abstract: Method and system for treating a patient using an inflatable device. A removal device may be used to remove the inflatable device from the body. The removal device can have at least one manually-actuatable member and at least two opposing jaws at a distal end. At least one of the at least two jaws can be movable by actuation of the at least one manually-actuatable member. At least one of the at least two jaws can have a puncturing member.Type: ApplicationFiled: April 25, 2014Publication date: August 21, 2014Applicant: ATTENUEX TECHNOLOGIES, INC.Inventors: Ryan J. Cahill, John Gillespie, JR., Peter Dayton, Kevin G. Connors
-
Publication number: 20140221732Abstract: An inflated implant within an anatomical structure, such as the bladder, may require removal. A method of removing an inflated implant from an anatomical structure can include any of a number of different steps. A removal device can be placed within the anatomical structure. The implant is located within the anatomical structure. After it is located, the implant can be engaged by arms of the removal device. A portion of a surface of the implant can be compromised such that an inflation substance within the implant can escape. The inflation substance can be removed out of the implant through a deflation tube in at least one of the arms used to engage the implant. The implant can then be removed from the anatomical structure.Type: ApplicationFiled: November 4, 2013Publication date: August 7, 2014Applicant: ATTENUEX TECHNOLOGIES, INC.Inventors: Peter Dayton, John Gillespie, JR., Kevin G. Connors
-
Patent number: 8721520Abstract: An implant delivery system can be configured to deliver an inflatable implant into a bladder via a urethra. The delivery system can comprise an elongate tubular body, an inflation tube and an implant decoupler. The tubular body can comprise a central lumen configured to hold an inflatable implant in an initial un-inflated state for delivery of the implant into the bladder. A method of use can include passing a distal tip of the elongate tubular body into the bladder. The implant can be inflated and released into the bladder.Type: GrantFiled: June 24, 2013Date of Patent: May 13, 2014Assignee: AttenueX Technologies, Inc.Inventors: Sheila Caira, John Gillespie, Jr., Peter Dayton, Kevin G. Connors
-
Publication number: 20140081076Abstract: An implant delivery system can be configured to deliver an inflatable implant into a bladder via a urethra. The delivery system can comprise an elongate tubular body, an inflation tube and an implant decoupler. The tubular body can comprise a central lumen configured to hold an inflatable implant in an initial un-inflated state for delivery of the implant into the bladder. A method of use can include passing a distal tip of the elongate tubular body into the bladder. The implant can be inflated and released into the bladder.Type: ApplicationFiled: November 25, 2013Publication date: March 20, 2014Applicant: ATTENUEX TECHNOLOGIES, INC.Inventors: Ernest G. Schutt, Kevin G. Connors, John Gillespie, JR., Peter Dayton
-
Publication number: 20140046124Abstract: Method and system for treating a patient using a compressible, pressure-attenuating device. According to one embodiment, the system is used to treat urinary tract disorders and can include one or more of an access device, a delivery device, a pressure-attenuating device, and a removal device. The access device may be used to create a passageway to an anatomical structure, such as the patient's bladder. The delivery device may be inserted through the passageway created by the access device and may be used to deliver the pressure-attenuating device to the anatomical structure. The removal device may be inserted through the passageway created by the access device and may be used to view the bladder and/or to capture, to deflate and to remove the pressure-attenuating device.Type: ApplicationFiled: September 5, 2013Publication date: February 13, 2014Applicant: ATTENUEX TECHNOLOGIES, INC.Inventors: Ryan J. Cahill, Kevin G. Connors
-
Publication number: 20140046125Abstract: Method and system for treating a patient using a compressible, pressure-attenuating device. According to one embodiment, the system is used to treat urinary tract disorders and can include one or more of an access device, a delivery device, a pressure-attenuating device, and a removal device. The access device may be used to create a passageway to an anatomical structure, such as the patient's bladder. The delivery device may be inserted through the passageway created by the access device and may be used to deliver the pressure-attenuating device to the anatomical structure. The removal device may be inserted through the passageway created by the access device and may be used to view the bladder and/or to capture, to deflate and to remove the pressure-attenuating device.Type: ApplicationFiled: October 24, 2013Publication date: February 13, 2014Applicant: ATTENUEX TECHNOLOGIES, INC.Inventors: John Gillespie, JR., Ryan J. Cahill, Kevin G. Connors, Peter Dayton, Carla Wiese
-
Publication number: 20140046123Abstract: Method and system for treating a patient using a compressible, pressure-attenuating device. According to one embodiment, the system is used to treat urinary tract disorders and comprises an access device, a delivery device, a pressure-attenuating device, and a removal device. The access device may be used to create a passageway to an anatomical structure, such as the patient's bladder. The delivery device may be inserted through the passageway created by the access device and may be used to deliver the pressure-attenuating device to the anatomical structure. The removal device may be inserted through the passageway created by the access device and may be used to view the bladder and/or to capture, to deflate and to remove the pressure-attenuating device.Type: ApplicationFiled: March 15, 2013Publication date: February 13, 2014Applicant: ATTENUEX TECHNOLOGIES, INC.Inventor: ATTENUEX TECHNOLOGIES, INC.
-
Patent number: 8574146Abstract: An implant for use in a human or animal body can include a flexible housing with an outer wall and having a chamber therein. The implant can have at least one high vapor pressure medium within the chamber. The at one high vapor pressure medium can have a combined vapor pressure equal to or greater than about the average value of the hydrostatic pressure of the implantation site plus the skin tension of the housing minus the gas tension of the dissolved gasses present at the implantation site.Type: GrantFiled: November 24, 2009Date of Patent: November 5, 2013Assignee: AttenueX Technologies, Inc.Inventors: John Gillespie, Jr., Kevin G. Connors, Ernest G. Schutt, Peter Dayton
-
Patent number: 8298132Abstract: Disclosed herein are methods of treating a patient with benign hypertrophy of the prostate, comprising providing a compressible attenuation device that is moveable from a first, introduction configuration to a second, implanted configuration and attenuating a pressure change within the bladder by reversibly changing the volume of the attenuation device in response to the pressure change. In one embodiment, the attenuation device is advanced percutaneously into the bladder. In another embodiment, the attenuation device is positioned within the bladder to inhibit a decrease in compliance of the bladder wall as a consequence of the benign hypertrophy of the prostate.Type: GrantFiled: December 23, 2008Date of Patent: October 30, 2012Assignee: AttenueX Technologies, Inc.Inventors: Kevin G. Connors, William L. Pintauro, Sheila K. Wallin, John T. Kilcoyne, Hung H. Cao, Khoi M. Nguyen, Mathew T. Yurek